Abbott Laboratories Co. is bringing back the megadeal like it’s 2015.
On Thursday, the Abbott Park, Illinois-based health care products manufacturer agreed to buy St. Paul, Minnesota-based St. Jude Medical Inc. in a $25 billion cash-and-stock deal. The transaction, expected to close in the fourth quarter of this year, is aimed at growing the would-be acquirer’s existing cardiovascular offerings and will also see Abbott assume or refinance $5.7 billion of St. Jude’s debt.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
